Cargando…
Reduction of microglial activity in a model of multiple sclerosis by dipyridamole
BACKGROUND: Despite extensive and persistent activation of microglia in multiple sclerosis (MS), microglia inhibitors have not yet been identified for treatment of the disorder. We sought to identify medications already in clinical use that could inhibit the activation of microglia. On the basis of...
Autores principales: | Sloka, Scott, Metz, Luanne M, Hader, Walter, Starreveld, Yves, Yong, V Wee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724584/ https://www.ncbi.nlm.nih.gov/pubmed/23866809 http://dx.doi.org/10.1186/1742-2094-10-89 |
Ejemplares similares
-
1,25-Dihydroxyvitamin D(3) Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis
por: Sloka, Scott, et al.
Publicado: (2015) -
Environmental factors and their regulation of immunity in multiple sclerosis
por: Koch, Marcus W., et al.
Publicado: (2013) -
Focus on the gut-brain axis: Multiple sclerosis, the intestinal barrier and the microbiome
por: Camara-Lemarroy, Carlos R, et al.
Publicado: (2018) -
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
por: Zhornitsky, Simon, et al.
Publicado: (2015) -
Expanding the Potential Therapeutic Options for Remote Ischemic Preconditioning: Use in Multiple Sclerosis
por: Camara-Lemarroy, Carlos R., et al.
Publicado: (2018)